2؉ /calmodulin-dependent protein kinase II (CaMK-II) isozyme variability is the result of alternative usage of variable domain sequences. Isozyme expression is cell type-specific to transduce the appropriate Ca 2؉ signals. We have determined the subcellular targeting domain of ␦ E CaMK-II, an isozyme that induces neurite outgrowth, and of a structurally similar isozyme, ␥ C CaMK-II, which does not induce neurite outgrowth. ␦ E CaMK-II co-localizes with filamentous actin in the perinuclear region and in cellular extensions. In contrast, ␥ C CaMK-II is uniformly cytosolic. Constitutively active ␦ E CaMK-II induces F-actin-rich extensions, thereby supporting a functional role for its localization. C-terminal constructs, which lack central variable domain sequences, can oligomerize and localize like full-length ␦ E and ␥ C CaMK-II. Central variable domains themselves are monomeric and have no targeting capability. The C-terminal 95 residues of ␦ CaMK-II also has no targeting capability but can efficiently oligomerize. These findings define a targeting domain for ␥ and ␦ CaMK-IIs that is in between the central variable and association domains. This domain is responsible for the subcellular targeting differences between ␥ and ␦ CaMK-IIs.
ticulum (4, 10, (13) (14) (15) (16) . CaMK-II holoenzyme is normally dodecameric, and targeting can be influenced by the heterooligomerization of CaMK-II monomers (16 -18) . For example, cytosolic CaMK-IIs can redirect nuclear-targeted isozymes to the cytosol by heterooligomerization (13, 19) . Properly targeted CaMK-IIs can influence cellular events unlike catalytically identical but mistargeted isozymes (20, 21) . CaMK-II localization can respond to the activation state of CaMK-II (15, 22) or to phosphorylation by other kinases (14) . Other than nuclear localization sequences, the targeting domains have not been defined for CaMK-II isozymes, particularly those encoded by the ␥ and ␦ genes.
Although ␣ and ␤ are the predominant CaMK-II genes transcribed in the central nervous system, ␦ isozymes are the most common CaMK-II gene product in embryonic cells (6, 8, 10, 12) . Mouse embryonic cells express some ␤ e , ␥ C , and ␥ B gene products but primarily express ␦ C CaMK-II (12, 21, 23) . During early mouse development, ␥ and ␦ CaMK-II gene products are the primary gene products expressed throughout the embryo including the developing nervous system (6) . ␦ CaMK-II isozymes have been implicated in rodent neuronal and muscle differentiation (12, 21, 24 -27) . Human ␦ E CaMK-II was originally cloned from neuroblastoma cells (8) . ␦ E is also known as ␦ 10 or ␦ 9 depending on the presence or absence of the C-terminal tail (11) . ␥ C CaMK-II was originally cloned from human T lymphocytes where it is particularly enriched (2), but its function is not known.
Both ␥ C and ␦ E CaMK-II encode 57-kDa proteins with one alternative exon in their central variable domain. Despite this structural similarity and the extranuclear location of both isozymes, only ␦ E induces neurite outgrowth (21) . Their catalytic properties are similar, suggesting that subtle targeting differences are responsible for their disparate functional roles. It is not known whether sequence differences in their one alternative exon are responsible for their targeting differences.
The intent of this work has been to define the targeting domain for both ␥ C and ␦ E CaMK-II. Green fluorescent protein (GFP)-linked deletion constructs of ␥ C and ␦ E CaMK-II were prepared, and their oligomeric nature and localization were evaluated. Our findings define a targeting domain that is located in between the central variable domain and the C-terminal association (oligomerization) domain. The localization of ␦ E CaMK-II suggests that it promotes neurite outgrowth through the stabilization of the actin cytoskeleton.
EXPERIMENTAL PROCEDURES
Cell lines and Culture-NIH/3T3 mouse embryo fibroblasts were cultured on polystyrene dishes in Dulbecco's modified Eagle's medium (BioWhitaker, Walkersville, MD) with 10% fetal bovine serum (Life Technologies, Inc.), supplemented with penicillin and/or streptomycin in a 5% CO 2 humidified chamber at 37°C.
cDNA Preparation-The first 301 and the last 22 amino acids encoded by full-length wild type or constitutively active CaMK-II cDNAs * This work was supported by grants from the Kate and Thomas Jeffress Foundation Trust and the R. Clifton Brooks fund for Biomedical Research and by National Science Foundation Grant 9904765. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.
‡ To whom correspondence should be addressed: Depts. of Biology and Biochemistry and Molecular Biophysics, Virginia Commonwealth University, P. O. Box 842012, Richmond, VA 23284-2012. Tel.: 804-827-0141; Fax: 804-828-0503; E-mail: rtombes@hsc.vcu.edu. 1 The abbreviations used are: CaMK-II, Ca 2ϩ /CaM-dependent protein kinase type II; GFP, green fluorescent protein; EGFP, enhanced green fluorescent protein; PBS, phosphate-buffered saline; TBSTA, Tris-buffered saline, pH 7.4, 0.05% Tween 20, 0.05% sodium azide. used in this study were identical as described previously (21) . Constitutively active mutants were prepared by point mutagenesis of Thr   287 to Asp 287 , which renders CaMK-II active in the absence of Ca 2ϩ /CaM. Using polymerase chain reaction-mediated directional cloning, CaMK-II cDNAs were linked to sequences encoding enhanced green fluorescent protein (EGFP) by using the vector pEGFP-C1 (CLON-TECH, Palo Alto, CA). EGFP is placed at the NH 2 terminus of CaMK-II with only one additional codon (encoding a glycine residue) separating the two sequences. Primers were synthesized containing restriction enzyme sites (BspE1 at the 5Ј end and BamHI at the 3Ј end) to amplify the desired cDNA fragment. They enabled the in-frame introduction of CaMK-II domains on the C-terminal side of EGFP. Proper clone construction was confirmed by DNA sequencing in both directions as described previously (21) by evaluation of enzymatic activity (for fulllength CaMK-IIs) and by anti-GFP immunoblotting. Sequence analysis was performed using Gene Jockey II (Biosoft, Inc, Cambridge, United Kingdom).
Transfection of DNA into Mammalian Cells-cDNAs encoding fulllength CaMK-II isozymes were transfected into NIH/3T3 cells using LipofectAMINE PLUS (Life Technologies, Inc.) for 3 h followed by culture for at least an additional 18 h. Transfection efficiencies routinely exceeded 50%.
Whole Cell Lysate Preparation-Transfected cells were grown for 1-2 days, harvested with trypsin-EDTA, and then washed with phosphate buffered saline (PBS) containing 2.5 mM EGTA. Pellets were resuspended in 3 volumes of ice-cold homogenization buffer, which consisted of 30 mM Hepes, pH 7.4, 2.6 mM EGTA, 20 mM MgCl 2 , 80 mM ␤-glycerol phosphate, 0.1 M okadaic acid (Life Technologies, Inc.), 0.01 mg/ml each chymostatin, leupeptin, aprotinin, pepstatin, and soybean trypsin inhibitor (Sigma). Samples were then sonicated (three 5-s bursts on ice), centrifuged at 10,000 ϫ g for 15 min at 4°C and either assayed immediately or frozen and stored at Ϫ80°C. Lysates prepared by sonication solubilized over 90% of the total CaMK-II activity as measured by solution assays and immunoblots (data not shown). Cytosolic fractions were diluted to 0.1-0.2 mg/ml protein in homogenization buffer, and 10 l was assayed for CaMK-II activity as described previously (21) .
Immunoblots-Whole cell lysates were separated on 10% polyacrylamide gels using the Mini-Protean II gel electrophoresis system (BioRad). Proteins were transferred to 0.45 m of nitrocellulose sheets for 1 h at 100V and blocked with TBSTA containing 2.5% nonfat dry milk, 2.5% bovine serum albumin, and 2% normal goat serum for 1 h. The anti-GFP antibody was a mouse monoclonal IgG (CLONTECH). Primary antibodies were typically diluted to 0.5 g/ml in 2% bovine serum albumin/TBSTA and incubated between 1 and 12 h with the nitrocellulose blot. Blots were washed three times with TBSTA and incubated for 1 h with 0.5 g/ml alkaline phosphatase-coupled goat anti-mouse IgG (Kierkegaard Perry Labs, Gaithersburg, MD) in 2% bovine serum albumin/TBSTA. Blots were developed with 0.25 mg/ml 5-bromo-4-chloro-3-indolyl phosphate and 0.25 mg/ml nitro blue tetrazolium (Sigma) in 0.1 M Tris, 0.1 M NaCl, 5 mM MgCl 2 , pH 9.4. Monomeric molecular weights of bands were interpolated from a linear plot of log M r of standards versus R F .
Native Molecular Weight Determinations-Whole cell lysates were filtered through 0.45-m syringe tip filters and then loaded onto a 40 ϫ 1.0-cm Superose-12 gel filtration column (Amersham Pharmacia Biotech, Inc., Piscataway, NJ) in 50 mM Tris, pH 7.4, 150 mM NaCl, 0.1 mM dithiothreitol, 5% glycerol, and 0.001 mg/ml each chymostatin, leupeptin, aprotinin, pepstatin, and soybean trypsin inhibitor. Superose-12 was the matrix chosen, because it spanned predicted monomeric and oligomeric CaMK-II sizes. The reported exclusion limit for Superose-12 is 2 ϫ 10 6 (Amersham Pharmacia Biotech). Retention times of standards, which included thyroglobulin (M r ϭ 669,000), ␤-amylase (M r ϭ 200,000), bovine serum albumin (M r ϭ 66,000), and carbonic anhydrase (M r ϭ 29,000), were determined from in-line absorbance at 280 nm. Sample fractions were assessed for GFP fluorescence using the Fluorstar fluorescence microtiter plate reader (B&L Systems, Maarsen, Holland) or with anti-GFP immunoblotting. Elution volumes (V e ) were plotted as a function of the void volume (V 0 ) and the total volume (V T ). V 0 was determined using blue dextran, and V T was determined using glycine. Native molecular weights of samples were interpolated from a linear plot of log M r of standards versus K av (V e Ϫ V 0 /V T Ϫ V 0 ) as described previously (28) .
Immunohistochemistry and Microscopy-Transfected fibroblasts were grown on polystyrene dishes or glass coverslips for 1-2 days after transfection. Cells were imaged either directly on a heated stage or after fixation. Fixation was routinely performed as follows. Coverslips were first rinsed in PBS, incubated with fresh 4% formaldehyde in PBS for 15 min, permeabilized with 0.05% Nonidet P-40 (Pierce) in PBS, and then post-fixed with 4% formaldehyde in PBS for 5 min. Cells were stained with 100 nM rhodamine-phalloidin (Cytoskeleton, Inc., Denver, CO) for actin, the AA2-purified mouse monoclonal antibody for total tubulin (courtesy of Dr. Anthony Frankfurter, University of Virginia) at 1 g/ml, or the V9 mouse monoclonal antibody (Sigma) for vimentin. For the latter two, 1 g/ml rhodamine-coupled goat anti-mouse IgG (Kierkegaard Perry Labs) in 2% bovine serum albumin/TBSTA was used as the secondary antibody. Cells were imaged using the Olympus Fastscan 2000 12-bit digital camera mounted on an Olympus IX70 fluorescent microscope (Olympus America, Melville, NY). Images were compiled using Photoshop 5.5 (Adobe Systems, Inc, San Jose, CA).
RESULTS

Expression and Characterization of CaMK-II Isozymes-To
characterize the minimal targeting domain of ␥ C and ␦ E CaMK-II, deletion constructs ( Fig. 1 , A-F) were linked at their NH 2 termini to EGFP. This and other labs have shown that the catalytic properties of GFP-linked full-length constructs (A) are not affected by an NH 2 -terminal GFP domain (18, 21 Fig. 1 . The sequence comprising these last 195 (␥ C ) or 192 (␦ E ) residues is shown with differences highlighted (Fig. 1) .
These 11-GFP-CaMK-II constructs were transfected into NIH/3T3 cells. After 2 days, cells were harvested and evaluated by anti-GFP immunoblots (Fig. 2) . As expected, full-length ␥ C and ␦ E migrated at 84 kDa, which was 27 kDa larger than full-length CaMK-II alone (A). All other constructs were proportionally smaller as predicted. Lysates containing transfected full-length CaMK-II exhibited Ca 2ϩ /CaM-dependent cat-
Constructs used in this study. CaMK-II constructs used in this study have GFP (27 kDa) linked at the NH 2 terminus to the constructs of ␥ C or ␦ E CaMK-II at the indicated residues. Approximate boundaries of the catalytic (residues 1-311), central variable (residues 312-361), and association (residues 362-492 or 365-495) domains are indicated by shading. ␥ C and ␦ E sequence alignment starts at residue 301 and is numbered according to ␥ C . Dots indicate identity, and bold residues in ␦ E CaMK-II represent differences. The C-terminal 22 residues of ␦ E CaMK-II was made identical to ␥ C CaMK-II to avoid complications of alternative C-terminal tails.
alytic activity, which exceeded total endogenous CaMK-II activity levels by at least 4-fold (21) . Predicted and observed monomeric molecular weights (M r ), as determined by SDSpolyacrylamide gel electrophoresis, are summarized in Table I .
Oligomerization Domain of ␥ and ␦ CaMK-II-CaMK-II targeting may depend upon oligomerization. Therefore, we evaluated the native molecular weights of all expressed constructs. Previous studies have indicated that the minimal oligomerization domain of ␣ CaMK-II begins approximately at Ala 384 (17) , which corresponds to Ala 398 in ␦ E CaMK-II. Other studies indicate that the ␣ CaMK-II association domain comprises the last 135 amino acids but is most dependent upon the last 110 residues (18) . The boundaries of the association domain had not yet been determined for ␥ or ␦ CaMK-IIs, but we expected constructs A, B, E, and possibly F to oligomerize based on homology to ␣ CaMK-II.
To assess oligomerization, lysates of cells transiently transfected with ␥ C and ␦ E CaMK-II constructs were applied to a Superose-12 gel filtration column (see under "Experimental Procedures"). Anti-GFP immunoblots demonstrated that protein constructs remained intact through gel filtration and peaked at different elution volumes (Fig. 3, ␦ E only) . Quantitative profiles for all constructs were obtained by analyzing the GFP fluorescence of each fraction (Fig. 3, bottom panels) . Elution profiles were plotted as a function of K av , and native sizes were interpolated (Table I) . For both ␥ C and ␦ E , constructs A, B, E, and F exhibited major peaks corresponding to oligomers of at least 9 subunits. Construct A had a substantial secondary peak corresponding to monomer and additional shoulders on both of these peaks. Constructs B, E, and F all had less relative contribution from their "monomeric" peaks and were, therefore, considered to have oligomerized more efficiently. Constructs C and D did not oligomerize whatsoever as they showed single peaks corresponding to their monomeric size. These results indicate that the C-terminal 142 residues of ␥ and ␦ CaMK-II can efficiently oligomerize, and that the C-terminal 95 amino acids of ␦ CaMK-II are sufficient for oligomerization.
Localization of Full-length ␥ and ␦ CaMK-II Isozymes-The localization patterns of full-length GFP-linked ␥ C and ␦ E CaMK-IIs were determined using conventional fluorescence microscopy of living cells 2 days after transfection. The populations of cells are shown at low magnification, and individual cells are shown at higher magnification using both phasecontrast and fluorescence illumination (Fig. 4) . Note that these images demonstrate the high transfection efficiencies typically obtained in these experiments. Both GFP-linked CaMK-IIs demonstrated localization patterns that were similar to both the indirect immunofluorescence pattern of transfected non-GFP-linked CaMK-IIs (21) and to endogenous CaMK-II determined by using gene-specific antibodies (12) . ␥ C CaMK-II exhibited a dispersed and uniform distribution throughout the cytoplasm. In contrast, ␦ E CaMK-II exhibited a distinctive perinuclear and cortical cytoplasmic staining as previously reported for endogenous ␦ CaMK-II in rodent fibroblasts, astrocytes, and myoblasts (10, 12, 27) .
Minimal ␥ and ␦ CaMK-II Targeting Domain-C-terminal construct B of ␥ C (Fig. 5, top row) and ␦ E (Fig. 5, bottom row) CaMK-II localized similar to full-length construct A. ␥ C was uniformly dispersed throughout the cytoplasm, whereas ␦ E showed cortical and perinuclear localization. High intensity fluorescent particles were occasionally seen with some constructs (see Fig. 5 , ␥ C constructs B and E and ␦ E constructs E and F).
Constructs C and D span the entire variable domain. Construct C ends within the first third of the association domain, whereas construct D encodes a smaller segment that ends in a region that links the variable and association domains (see Fig.  1 ). Neither construct exhibited any targeting, as they were found throughout the cytoplasm and nucleus in an identical pattern to GFP alone (Fig. 1, GFP panel, top row) . GFP is slightly more enriched in the nucleus but is not exclusively found in the nucleus.
Construct E has a normal C terminus but begins at either Thr 354 (␥) or Thr 351 (␦) and thus lacks any variable domain sequences. Construct E is oligomeric (see Table I ). Although it was lacking variable domain sequences, construct E localized much like constructs A or B, i.e. it exhibited the striking perinuclear distribution for ␦ and the dispersed cytoplasmic localization for ␥ CaMK-II.
Construct F was prepared for ␦ CaMK-II only. This 95 amino acid domain begins at Ala 399 and continues to the C terminus. This construct is synthesized at its predicted size and is efficiently oligomeric at 11 times its monomeric size ( Fig. 3 and Table I ). ␦ Construct F, however, was not targeted like fulllength ␦ E constructs A, B, or E. Like GFP alone, ␦ construct F was found throughout the cell in both the nucleus and the cytoplasm, but unlike GFP, it was oligomeric and often seen as small cytoplasmic fluorescent particles (Fig. 5) .
These findings indicate that alternative exons in the central variable domain are not necessary for cytoplasmic targeting of ␥ and ␦ CaMK-IIs. Rather, the sequence that comprises the difference between constructs E and F is necessary for targeting. Further support for this conclusion comes from our observations that GFP-linked ␦ C CaMK-II oligomerizes and localizes in an identical perinuclear fashion to ␦ E . The ␦ C gene product is a ␦ CaMK-II isozyme, which naturally lacks alternative variable domain sequences (21) .
Co-localization and Influence of ␦ CaMK-IIs on the Actin Cytoskeleton-Living cells transfected with full-length ␦ E construct A or C-terminal constructs B and E often exhibited filaments in the perinuclear region. These filaments were more easily seen when cells were permeabilized and fixed (Fig. 6 ). ␥ C CaMK-II constructs did not exhibit these filaments. The ␦ E filamentous pattern was observed even when cells were detergent washed or extracted, which supports a co-localization with the cytoskeleton and not endomembranes. Therefore, fixed cells were counterstained with antibodies against tubulin or vimentin and were counterstained with phalloidin for actin. ␦ E CaMK-II co-localized with F-actin around the nucleus and at the cell cortex. The arrows point out some of these co-localizing CaMK-II and actin fibers (Fig. 6 ). Vimentin and tubulin fibers were enriched in the perinuclear region but not in the same bundles or fibers as CaMK-II and actin. CaMK-II did not colocalize with actin stress fibers, the predominant actin structure in these cells. A particularly striking-merged color image of a ␦ E CaMK-II pattern (green) with F-actin (red) reveals co-localizing yellow filaments passing around and above the nucleus and into a short actin-rich extension (Fig. 7) . Actin stress fibers can be seen as fibers that run along the base of the cell and do not co-localize with CaMK-II. Fig. 1 were separated by SDS-polyacrylamide gel electrophoresis and reacted with a monoclonal antibody directed against GFP.
From this actin co-localization and our previous finding that constitutively active GFP-linked ␦ E CaMK-II can induce neurite outgrowth (21), we predicted that transfected constitutively active ␦ E CaMK-II might induce actin polymerization and demonstrate a more pronounced co-localization with actin, and this is what we observed. ␦ E CaMK-II co-localized with enhanced levels of F-actin along the entire length of the cellular extensions that it induced, particularly at the tip (Fig. 8,  middle panel) . Cells that were not transfected or were transfected with constitutively active ␥ C CaMK-II exhibited normal actin patterns and showed no extensions (Fig. 8, top panel) . Both of these constitutively active constructs were previously shown to exhibit high levels of autonomous (Ca 2ϩ /CaM-independent) activity (21) . At a higher magnification, constitutively active ␦ E CaMK-II could be seen at the tips of these extensions in a pattern that co-localized with bundled and cortical F-actin (Fig. 8, bottom panel) . We interpret these results as indicating that cellular extensions are formed in the presence of constitutively active ␦ E CaMK-II through either the induction or stabilization of actin fibers.
DISCUSSION
Cytosolic CaMK-II activity is involved in the differentiation of adipocytes, myocytes, and pre-neuronal cells (24, 29 -34) . Of the four CaMK-II genes, ␦ CaMK-II gene products are the most highly expressed in these cells and have been shown to directly induce neuritogenesis (12, 21, 25) . Most CaMK-II gene products are strikingly similar in structural and kinetic features, leading to the conclusion that ␦ CaMK-IIs, like other protein kinases, must be selectively targeted to substrates to influence events such as neurite outgrowth. In this study, we have dem- 3 . Native M r of GFP-CaMK-II constructs. Superose-12 gel filtration fractions of representative ␦ E CaMK-II constructs A, B, C, E, and F were assessed by anti-GFP immunoblot analysis (top panel) and are shown as a function of K av (V e Ϫ V 0 /V T Ϫ V 0 ). The immunoreactivity of the column starting material (SM) for each construct is shown in the last lane. Elution profiles of all constructs were also assessed by quantitative GFP fluorescence analysis (bottom plots). Native molecular masses were interpolated to the nearest 5 kDa (Table I) onstrated that ␦ E CaMK-II, an isozyme independently discovered in heart and pre-neuronal cells (8, 11, 21) , co-localizes with F-actin in the perinuclear region and at the cell periphery. This is the identical localization for endogenous ␦ CaMK-II in mouse embryonic fibroblasts (12) , rat myoblasts (27) , and rat astrocytes (10) . When ␦ E CaMK-II is made constitutively active and is transfected, it induces cellular extensions (21), localizes along and at the tips of these cellular extensions, and increases filamentous F-actin. ␥ C CaMK-II, a catalytically and structurally similar isozyme originally found at high levels in T lymphocytes (35) , is found in the cytosol but does not induce neurite outgrowth and does not co-localize with F-actin.
We have also shown that ␥ C and ␦ E CaMK-II targeting is not dependent on the central variable domain. Constructs C and D target no differently than GFP alone, whereas C-terminal construct E, which lacks central variable domain sequences, targets like full-length CaMK-II. This finding was somewhat surprising, because there are ␥ and ␦ CaMK-II isozymes that have central variable domain (nuclear)-targeting sequences (10, 13, 14) . Because ␦ targeting does not require alternative exons in the variable domain, the ␦ E CaMK-II targeting shown here represents the "default" targeting pattern for ␦ gene products such as ␦ C CaMK-II, which is the principal ␦ CaMK-II isozyme expressed in embryonic cells (6, 8, 10, 12, 21 ). This conclusion is consistent with our finding that ␦ C and ␦ E CaMK-II show identical localization and are equally capable of inducing neurite outgrowth (21) .
The variable domains of both ␦ C and ␣ CaMK-II are structurally similar (8) , i.e. they lack alternative exons and are therefore the simplest products of their respective genes. Whereas ␦ C CaMK-II has targeting sequences in the C-terminal domain, ␣ CaMK-II can be targeted to the post-synaptic density by heterooligomerization with ␤ CaMK-II (19) or to the sarcoplasmic reticulum by heterooligomerization with ␣KAP (9). Although we have now shown that central variable domain sequences are not necessarily required for CaMK-II targeting, it is undoubtedly clear that proper targeting is necessary for CaMK-II function.
␥ C CaMK-II and ␦ E CaMK-II targeting requires only the last 150 residues, which does not include the central variable domain. Our findings indicate that the first 50 residues of this C-terminal domain are necessary for targeting, and the last 95 residues are minimally necessary for oligomerization. Therefore, targeting is dependent upon oligomerization, but oligomerization alone does not result in targeting. The 50 amino acid domain corresponds to ␦ E Thr 351 -Ala 399 ( Fig. 1) , which is analogous to ␣ Thr 337 -Ala 384 . In a model of full-length oligomeric ␣ CaMK-II, this domain is part of a linker between the NH 2 -terminal peripheral catalytic domain and the C-terminal association domain, which form a central oligomeric core (36) . This creates the structural potential for the interaction of this domain with other proteins. Oligomerization has also been reported as necessary for CaMK-II targeting to the NR2B subunit of the N-methyl, D-aspartate receptor, although the targeting sequences are found in the catalytic domain (37) . Regardless of where the targeting domain resides, its juxtaposition as an oligomer may present a unique three-dimensional targeting site that is not present in monomeric CaMK-II. Both ␥ C and ␦ E CaMK-II are composed of three separate exons in their variable region (8) . This has been confirmed through the examination of the human ␦ CaMK-II gene on chromosome four (4q25) and the human ␥ CaMK-II gene on chromosome 10 (10q22) via sequence analysis through the National Center for Biotechnology Information. The second of these three exons (␦ E 329 -342 , EPQTTVIHNPDGNK) contains some unique and repeated sequence elements that are absent from ␥ C (21) . This exon, however, is not responsible for ␦ CaMK-II targeting to the perinuclear region as described here. Although the function of this domain is not yet known in ␦ CaMK-II, the analogous ␥ domain (EPQTTVVHNATDGIK) is used in ␥ A CaMK-II to regulate the targeting of a preceding nuclear targeting domain (10) . However, no known ␦ CaMK-II expresses this domain in combination with the nuclear targeting domain (8) .
CaMK-II has been reported to form 100-nm "clusters" in cultured hippocampal neurons (38) . It is not clear what constitutes the molecular basis of these clusters, but we do not believe that they are related to the much larger fluorescent particles as described here. The particles observed here were seen only with oligomeric constructs A, B, E, and F and, therefore, were not an artifact of EGFP by itself. They were most prominent with ␦ construct F, which interestingly was the only oligomeric construct that lacked any subcellular targeting capability. We also observed these particles more often with ␥ C than with ␦ E oligomeric constructs. We suspect that when overexpressed oligomeric CaMK-IIs exceed the level of endogenous binding partners, they are more prone to cellular disposal pathways, appearing as accumulations of fluorescence.
In this study, we have shown that differentially effective ␥ and ␦ CaMK-II isozymes are differentially targeted. ␦ E CaMK-II co-localizes with F-actin in the perinuclear region and the cellular cortex in a manner that is consistent with its role in neuritogenesis. Our evidence indicates that the targeting of ␦ E CaMK-II is dependent on sequences residing between Thr 351 and Ala 398 . Targeting is also dependent upon oligomerization but not on the central variable domain. ␦ CaMK-II oligomerization requires no more than the last 95 residues. Further identification of binding targets and substrates of ␦ CaMK-II isozymes will help identify their precise locus of action and may account for known effects of Ca 2ϩ -dependent protein phosphorylation on neurite stabilization, outgrowth, and turning (39 -41) .
